About this episode

This episode explores the challenges in diagnosing brain tumours and the broader implications for cancer care in Britain.

Brain tumours are rare, but the gaps around them reveal something much bigger about modern cancer care. In this episode, we unpack why brain tumours are still so often diagnosed in crisis, with nearly half found in emergency settings in England. We explore why symptoms can be missed, why survival remains among the lowest of major cancers, and why access to specialist tests, genome sequencing, clinical trials and rehabilitation can still depend on where a patient is treated. We also look at the surprising role of something as ordinary as a freezer — and how tissue storage can shape diagnosis, research and future treatment options. At the heart of the story is a difficult question: if Britain has promised better cancer care, research investment and precision medicine, why are so many brain tumour patients still waiting for that promise to reach them? This is a story about science, systems, survival — and the cancer Britain still too often catches too late.

Mentioned in this episode

Organizations: Britain, England

Products: genome sequencing, clinical trials, rehabilitation

Places: A&E

Explore listener stats, chart rankings, contacts and more on the Deep Dive podcast page.